Form 4: Petmed Express CEO Receives Stock Grant
Insider Transaction (Form 4)
Jeffrey Allen Willard, CEO and President and a Director of Petmed Express Inc, reported multiple transactions in common stock on September 28, 2026.
Summary
- Grant/award: acquired 250,000 Common Stock on September 28, 2026; holds 250,000 after (Direct).
- Grant/award: acquired 250,000 Performance Share Units on September 28, 2026; holds 250,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffrey Allen Willard — Director, Officer (CEO and President)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Grant/award | Common Stock | 250,000 | — | — | 250,000 |
| 2026-09-28 | Grant/award | Performance Share Units | 250,000 | — | — | 250,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Grant/award (250,000 shares) |
| 2026-09-28 | Grant/award (250,000 shares) |
Keywords
insider transaction, Form 4, PETS, PETMED EXPRESS INC, neutral, Jeffrey Allen Willard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.